Skip to main content
Clinical Trials/NCT03821584
NCT03821584
Terminated
Not Applicable

Brain Perfusion Assessment in the Acute Phase of Migraine Aura.

Nantes University Hospital1 site in 1 country25 target enrollmentMarch 1, 2019
ConditionsEmergencies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emergencies
Sponsor
Nantes University Hospital
Enrollment
25
Locations
1
Primary Endpoint
Perfusion pattern of concerned brain areas
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The aim of the study is to determine the proportion of patients with change in brain perfusion during the acute phase of migraine attack with aura.

Detailed Description

Migraine is a benign and frequent disorder. Migraine aura consists in reversible focal neurological symptoms developing gradually during attack. Its diagnosis relies mainly on patient's history, clinical examination and exclusion of other possible secondary causes to explain transient neurological signs. Thus it can be difficult particularly during first attack or during attack without headache to differentiate migraine aura from transient ischemic stroke. Considering the difference of care management and prognosis, an early distinction of migraine aura based on imaging techniques will have a particular interest. MRI with diffusion, SWI, Flair 2D, ARM 3D TOF, ASL sequences' are routinely performed for the management of acute neurological deficit. Arterial spin labeling (ASL), as a MR perfusion method, will be used to describe brain perfusion during migraine aura. The study hypothesis is that hyperperfusion occurs in brain territories corresponding to the neurological symptoms during migraine aura.

Registry
clinicaltrials.gov
Start Date
March 1, 2019
End Date
July 22, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age between greater than or equal to 18
  • Able to undergo MRI during migraine aura

Exclusion Criteria

  • Pregnant females
  • Contraindications towards MRI scanning
  • History of epilepsy, psychiatric disease, or any other neurologic disease (brain tumors, stroke..).
  • Presence of abnormalities on the MRI that could explain the neurological deficit.
  • Adults under guardianship or trusteeship

Outcomes

Primary Outcomes

Perfusion pattern of concerned brain areas

Time Frame: 1 hour

Presence or absence of hypo-hyperperfusion using arterial spin labeling. Visual assessments and comparison between hemispheres

Secondary Outcomes

  • Pattern of perfusion and aura duration(12 month)

Study Sites (1)

Loading locations...

Similar Trials